Trial Identifier: | D419CC00026 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05667064 |
Start Date: | May 2023 |
Primary Completion Date: | December 2026 |
Study Completion Date: | December 2026 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Japan | Aomori, Japan |
Japan | Chiba, Japan |
Japan | Ehime, Japan |
Japan | Fukuoka, Japan |
Japan | Hokkaido, Japan |
Japan | Hyogo, Japan |
Japan | Iwate, Japan |
Japan | Kagawa, Japan |
Japan | Kanagawa, Japan |
Japan | Kyoto, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Miyagi, Japan |
Japan | Nagasaki, Japan |
Japan | Okayama, Japan |
Japan | Osaka, Japan |
Japan | Saitama, Japan |
Japan | Tokushima, Japan |
Japan | Tokyo, Japan |
Japan | Wakayama, Japan |